Alira Health

Alira Health

Our Parallel Trade Expertise

Reports
Published on:
November 1, 2020
Written by:
Mark Inigo Jones, Nerea Blanque-Catalina, and Filippo Benetti

Alira Health is proud to announce our new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.

Mark brings his extensive knowledge and expertise in parallel trade management to enhance Alira Health’s Market Access practice and Parallel Trade specialty, which includes 50% of the top 100 pharmaceutical companies.

For more information about Alira Health’s Market Access services

Click here

Related news

Case Studies March 26, 2024
Pharma Company Overcomes Launch Challenges with Patient-Centric Strategy
Our patient engagement team helped this pharma client identify the drivers behind the challenges they faced with their product launch.
Patient Centricity Patient Engagement Pharma
Articles March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Case Studies March 12, 2024
Pharma Company Adopts a Patient-Centric Value Proposition for Regulatory and Payer Dossier
A pharma company had a wealth of patient data on a product in development and they wanted to create a long-term strategy that would create a continuity of patient engagement across(...)
Patient Centricity Patient Engagement Pharma
Scientific Articles March 7, 2024
Randomized Controlled Trial Evidence of Cost-Effectiveness of a Multifaceted AKI Intervention Approach
Acute kidney injury (AKI) is linked to elevated healthcare usage and greater expenses. The Tackling AKI study, a pragmatic, multicenter, stepped-wedge cluster randomized trial, showcased(...)
Advanced Analytics Clinical Trials
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News February 7, 2024
Alira Health Advises Aesculapius Farmaceutici Srl in Its Acquisition by Ceres Pharma NV
We are pleased to have represented as transaction advisor Aesculapius, a leading Italian pharmaceutical company active in the development and distribution of prescription drugs, OTC(...)
Pharma Transaction Advisory
News January 26, 2024
Alira Health’s CDD Supports Alcami Acquisition of Pacific Pharmaceutical Services
We are pleased to have been an advisor on Alcami’s acquisition of Pacific Pharmaceutical Services (PPS). Alira Health advised Alcami, a leading Contract Development Manufacturing(...)
CDD CDMO Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.